Gisondi, P., Loconsole, F., Raimondo, P., & Ravasio, R. (2021). Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment, 8(1), 120–130. https://doi.org/10.33393/grhta.2021.2258